Почетна › Глиом › Њујорк › New York City
Kliničke studije za Глиом u gradu New York City, NY
26 studija za Глиом traži učesnike na lokacijama u gradu New York City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of Mirdametinib in People With Central Nervous System Tumors
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Тражи се учесникФаза 2
- Columbia University Irving Medical Center, New York
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Тражи се учесник
- NYU Langone Health, New York
Observational Connectomics in Adults Undergoing Resection of WHO II-IV Glioma
Тражи се учесникОпсервациона студија
- Lenox Hill Brain Tumor Center, New York
Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
Тражи се учесникФаза 2
- NYU Langone Health, New York
- Columbia University Medical Center, New York
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
Тражи се учесникФаза 1
- NYU Langone Health, New York
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Тражи се учесникФаза 1/2
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Тражи се учесникФаза 3
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- и још 1
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
Тражи се учесник
- Memorial Sloan Kettering Cancer Center, New York
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- Research Site, New York
- Research Site, New York
Glioma Developmental and HyperActive Ras Tumor (DHART) Board
Тражи се учесникОпсервациона студија
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
Тражи се учесникФаза 1
- New York University, New York
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Тражи се учесникФаза 4
- New York Presbyterian Hospital-Columbia University Medical Center, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Тражи се учесникФаза 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
Chronic CED of TPT for Recurrent Malignant Glioma
Тражи се учесникФаза 1
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
A Study of 177Lu-PSMA-617 in People With Gliomas
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Тражи се учесник
- Lenox Hill Brain Tumor Center, New York
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Тражи се учесникФаза 3
- Lenox Hill Brain Tumor Center, New York
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
Тражи се учесник
- Lenox Hill Brain Tumor Center, New York
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Тражи се учесникФаза 1
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Columbia University Medical Center, New York
- Memorial Slone Kettering Cancer Center, New York
Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
Тражи се учесникФаза 1
- Memorial Sloan Kettering, New York
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Тражи се учесникФаза 2
- Lenox Hill Brain Tumor Center, New York
FUS Etoposide for DMG
Тражи се учесникФаза 1
- Columbia University Irving Medical Center, New York
Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas
Тражи се учесникРана фаза 1
- NYU Langone Health, New York
Studije za Глиом u drugim gradovima
- Houston, TX24 студија
- Boston, MA19 студија
- Washington, DC17 студија
- Philadelphia, PA15 студија
- Columbus, OH15 студија
- San Francisco, CA15 студија
- Miami, FL15 студија
- Durham, NC12 студија
- Chicago, IL12 студија
- Los Angeles, CA11 студија
- Aurora, CO10 студија
- Seattle, WA10 студија
Ostale studije u gradu New York City
- Рак дојке144 студија
- Немалоклетни карцином плућа123 студија
- Рак (све врсте)105 студија
- Рак простате101 студија
- Метастатски карцином93 студија
- Колоректални карцином86 студија
- Рак јајника75 студија
- Рак плућа60 студија
- Многи мијелом59 студија
- Рак панкреаса57 студија
- Карцином ендометријума54 студија
- Akutna mijeloidna leukemija51 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.